Low molecular weight heparin drug found effective in IVF-ET
Enoxaparin, a low-molecular weight heparin, is getting praise from the Journal of Human Fertility for its safety and effectiveness for the prophylactic treatment of women with thrombophilia and recurrent in vitro fertilization-embryo transfer (IVF-ET) failures, according to IVG News.Direct!
Read the rest of this entry »
![[ Beasley Allen Law Firm Logo ]](http://www.heparin-legal.com/wp-content/themes/system-unity/images/logo.png)
